 <h1>Micardis HCT Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>hydrochlorothiazide / telmisartan</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about hydrochlorothiazide / telmisartan. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Micardis HCT.</p><h2>In Summary</h2><p><b>More frequent side effects include:</b> dizziness.  See below for a comprehensive list of adverse effects.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to hydrochlorothiazide / telmisartan: oral tablet</i></p><h3>Warning</h3><p class="blackboxWarning-title">Oral route (Tablet)</p><p>Drugs with direct action on the renin-angiotensin system can cause injury or death to the developing fetus when used during pregnancy. Stop therapy as soon as possible if pregnancy occurs.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, hydrochlorothiazide/telmisartan may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking hydrochlorothiazide / telmisartan:</p><p>
<i>Less common</i>
</p><ul>
<li>Bladder pain</li>
<li>bloody or cloudy urine</li>
<li>blurred vision</li>
<li>confusion</li>
<li>decreased urine</li>
<li>difficult, burning, or painful urination</li>
<li>dizziness, faintness, or lightheadedness when getting up from a lying or sitting position</li>
<li>dry mouth</li>
<li>fainting</li>
<li>fast, pounding, or irregular heartbeat or pulse</li>
<li>frequent urge to urinate</li>
<li>increased thirst</li>
<li>loss of appetite</li>
<li>lower back or side pain</li>
<li>muscle pain or cramps</li>
<li>nausea or vomiting</li>
<li>numbness or tingling in the hands, feet, or lips</li>
<li>seizures</li>
<li>sudden sweating</li>
<li>trouble breathing</li>
<li>unusual tiredness or weakness</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Chills</li>
<li>cold sweats</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or sex organs</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Persistent non-healing sore</li>
<li>pink growth</li>
<li>reddish patch or irritated area</li>
<li>shiny bump</li>
<li>white, yellow or waxy scar-like area</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of hydrochlorothiazide / telmisartan may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Body aches or pain</li>
<li>cough</li>
<li>difficulty breathing</li>
<li>dizziness</li>
<li>ear congestion</li>
<li>fever</li>
<li>headache</li>
<li>loss of voice</li>
<li>runny or stuffy nose</li>
<li>sneezing</li>
<li>sore throat</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Acid or sour stomach</li>
<li>back pain</li>
<li>belching</li>
<li>blistering, peeling, loosening of the skin</li>
<li>cough producing mucus</li>
<li>diarrhea</li>
<li>heartburn</li>
<li>hoarseness</li>
<li>indigestion</li>
<li>itching</li>
<li>joint pain</li>
<li>loss of appetite</li>
<li>muscle aches and pains</li>
<li>pain or tenderness around the eyes and cheekbones</li>
<li>rash</li>
<li>red irritated eyes</li>
<li>red skin lesions, often with a purple center</li>
<li>shivering</li>
<li>sores, ulcers, or white spots in the mouth or on the lips</li>
<li>stomach pain</li>
<li>sweating</li>
<li>tender, swollen glands in the neck</li>
<li>tightness in the chest</li>
<li>trouble sleeping</li>
<li>trouble swallowing</li>
<li>voice changes</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Decreased interest in sexual intercourse</li>
<li>inability to have or keep an erection</li>
<li>loss in sexual ability, desire, drive, or performance</li>
</ul><p>
<!-- end oral tablet --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to hydrochlorothiazide / telmisartan: oral tablet</i></p><h3>General</h3><p>The most common adverse effect was upper respiratory tract infection.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Sinusitis, upper respiratory tract infection, cough</p>
<p><b>Uncommon</b> (0.1% to 1%): Dyspnea</p>
<p><b>Rare</b> (less than 0.1%): Bronchitis, pharyngitis, respiratory distress, pneumonitis, pulmonary edema</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Very common</b> (10% or more): Upper respiratory tract infection (10%)</p>
<p><b>Common</b> (1% to 10%): Sinusitis</p>
<p><b>Frequency not reported</b>: Respiratory distress, pneumonitis, pulmonary edema</p>
<p></p>
<p>Telmisartan:</p>
<p><b>Common</b> (1% to 10%): Sinusitis, upper respiratory tract infection</p>
<p><b>Uncommon</b> (0.1% to 1%): Cough</p>
<p><b>Frequency not reported</b>: Asthma, rhinitis, dyspnea, epistaxis</p>
<p><b>Postmarketing reports</b>: Interstitial lung disease<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, influenza-like symptoms, pain</p>
<p><b>Uncommon</b> (0.1% to 1%): Chest pain</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Common</b> (1% to 10%): Fatigue, influenza-like symptoms</p>
<p><b>Frequency not reported</b>: Weakness, pyrexia</p>
<p></p>
<p>Telmisartan:</p>
<p><b>Common</b> (1% to 10%): Fatigue, influenza-like symptoms</p>
<p><b>Uncommon</b> (0.1% to 1%): Asthenia</p>
<p><b>Frequency not reported</b>: Earache, fever, malaise, leg edema, peripheral edema, dependent edema, chest pain</p>
<p><b>Postmarketing reports</b>: Weakness, edema, face edema, pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, headache</p>
<p><b>Uncommon</b> (0.1% to 1%): Syncope, paresthesia, vertigo</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Common</b> (1% to 10%): Dizziness</p>
<p><b>Frequency not reported</b>: Lightheadedness</p>
<p></p>
<p>Telmisartan:</p>
<p><b>Common</b> (1% to 10%): Dizziness</p>
<p><b>Rare</b> (less than 0.1%): Somnolence</p>
<p><b>Frequency not reported</b>: Tinnitus, migraine, hypoesthesia, cerebrovascular disorder, vertigo, paresthesia, hypoesthesia, involuntary muscle contraction</p>
<p><b>Postmarketing reports</b>: Headache, syncope<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, nausea</p>
<p><b>Uncommon</b> (0.1% to 1%): Dry mouth, flatulence</p>
<p><b>Rare</b> (less than 0.1%): Abdominal pain, constipation, dyspepsia, vomiting, gastritis</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Common</b> (1% to 10%): Diarrhea, nausea</p>
<p><b>Frequency not reported</b>: Sialadenitis, pancreatitis, stomach discomfort, cramping, gastric irritation</p>
<p></p>
<p>Telmisartan:</p>
<p><b>Common</b> (1% to 10%): Diarrhea, nausea</p>
<p><b>Rare</b> (less than 0.1%): Stomach discomfort</p>
<p><b>Frequency not reported</b>: Hemorrhoids, gastroenteritis, enteritis, gastroesophageal reflux, toothache, non-specific gastrointestinal disorder, flatulence, constipation, gastritis, dry mouth, </p>
<p><b>Postmarketing reports</b>: Dyspepsia, abdominal pain<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): BUN increased 11.2 mg/dL or greater, serum creatinine increased 0.5 mg/dL or greater</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Nephritis interstitial, renal dysfunction, renal failure</p>
<p></p>
<p>Telmisartan:</p>
<p><b>Uncommon</b> (0.1% to 1%): Renal impairment, acute renal failure<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p>
<p><b>Uncommon</b> (0.1% to 1%): Erectile dysfunction</p>
<p><b>Frequency not reported</b>: Impotence</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Glycosuria</p>
<p></p>
<p>Telmisartan:</p>
<p><b>Uncommon</b> (0.1% to 1%): Urinary tract infection</p>
<p><b>Frequency not reported</b>: Micturition frequency, cystitis, impotence</p>
<p><b>Postmarketing reports</b>: Erectile dysfunction<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Hemoglobin decreased 2 g/dL or greater</p>
<p><b>Uncommon</b> (0.1% to 1%): Hematocrit decreased 9% or more</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Aplastic anemia, hemolytic anemia, bone marrow depression, leukopenia, neutropenia, agranulocytosis, thrombocytopenia</p>
<p></p>
<p>Telmisartan:</p>
<p><b>Uncommon</b> (0.1% to 1%): Anemia</p>
<p><b>Rare</b> (less than 0.1%): Eosinophilia, thrombocytopenia, hemoglobin decreased<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Tachycardia, arrhythmias, hypotension, orthostatic hypotension</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Vasculitis necrotizing</p>
<p></p>
<p>Telmisartan:</p>
<p><b>Uncommon</b> (0.1% to 1%): Bradycardia</p>
<p><b>Frequency not reported</b>: Palpitation, angina pectoris, abnormal ECG, flushing, hypertension</p>
<p><b>Postmarketing reports</b>: Atrial fibrillation, congestive heart failure, myocardial infarction, blood pressure increased, hypertension aggravated, hypotension, postural hypotension<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Back pain, muscle spasm, myalgia</p>
<p><b>Rare</b> (less than 0.1%): Arthralgia, muscle cramp, pain in limb, blood creatine phosphokinase increased</p>
<p><b>Frequency not reported</b>: Leg pain, cramps in legs</p>
<p><b>Postmarketing reports</b>: Exacerbation or activation of systemic lupus erythematosus</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Lupus-like syndrome, muscle spasm</p>
<p></p>
<p>Telmisartan:</p>
<p><b>Rare</b> (less than 0.1%): Arthrosis, tendon pain, tendonitis, tenosynovitis</p>
<p><b>Frequency not reported</b>: Arthritis, arthralgia, leg pain, leg cramps, myalgia</p>
<p><b>Postmarketing reports</b>: Back pain, muscle cramps, creatine phosphokinase increased, rhabdomyolysis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Hypokalemia, blood uric acid increased</p>
<p><b>Rare</b> (less than 0.1%): Hyperuricemia, hyponatremia</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Diabetes mellitus inadequate control, anorexia, appetite decreased, electrolyte imbalance, hypercholesterolemia, hyperglycemia, hypovolemia, triglycerides increased, hyperuricemia</p>
<p></p>
<p>Telmisartan:</p>
<p><b>Uncommon</b> (0.1% to 1%): Hyperkalemia</p>
<p><b>Rare</b> (less than 0.1%): Hypoglycemia in diabetic patients</p>
<p><b>Frequency not reported</b>: Diabetes mellitus, gout, hypercholesterolemia</p>
<p><b>Postmarketing reports</b>: Uric acid increased<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Anxiety</p>
<p><b>Rare</b> (less than 0.1%): Depression, insomnia, sleep disorder</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Restlessness</p>
<p></p>
<p>Telmisartan:</p>
<p><b>Frequency not reported</b>: Nervousness, insomnia, anxiety, depression<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Rare</b> (less than 0.1%): Angioedema, erythema, pruritus, rash, hyperhidrosis, urticaria</p>
<p><b>Frequency not reported</b>: Sweating increased</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Photosensitivity reactions, skin vasculitis, toxic epidermal necrolysis, cutaneous lupus erythematosus-like reactions, reactivation of cutaneous lupus erythematosus, erythema multiforme, Stevens-Johnson syndrome, exfoliative dermatitis, purpura, urticaria</p>
<p></p>
<p>Telmisartan:</p>
<p><b>Rare</b> (less than 0.1%): Eczema, drug eruption, toxic skin eruption, toxicoderma, rash, angioedema</p>
<p><b>Frequency not reported</b>: Dermatitis, sweating increased, pruritus</p>
<p><b>Postmarketing reports</b>: Urticaria, erythema<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Rare</b> (less than 0.1%): Abnormal hepatic function/liver disorder, hepatic enzyme increased</p>
<p><b>Frequency not reported</b>: Serum bilirubin increased</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Jaundice hepatocellular, jaundice cholestatic</p>
<p></p>
<p>Telmisartan:</p>
<p><b>Postmarketing reports</b>: Abnormal hepatic function/liver disorder<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Rare</b> (less than 0.1%): Visual disturbance, vision blurred</p>
<p></p>
<p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Xanthopsia, acute myopia, acute angle-closure glaucoma, transient blurred vision</p>
<p></p>
<p>Telmisartan:</p>
<p><b>Frequency not reported</b>: Conjunctivitis, abnormal vision<sup>[Ref]</sup></p><h3>Immunologic</h3><p>Hydrochlorothiazide:</p>
<p><b>Frequency not reported</b>: Anaphylactic reactions, hypersensitivity, allergy</p>
<p></p>
<p>Telmisartan:</p>
<p><b>Rare</b> (less than 0.1%): Sepsis, hypersensitivity, anaphylactic reactions</p>
<p><b>Frequency not reported</b>: Allergy, infection, fungal infection, abscess, otitis media<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Micardis (hydrochlorothiazide-telmisartan)" Boehringer-Ingelheim, Braintree, MA. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Micardis HCT (hydrochlorothiazide / telmisartan)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>14 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: angiotensin II inhibitors with thiazides</li>
<li>FDA Alerts (1)</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Micardis HCT &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul>
<h3>Other Formulations</h3>
<ul class="more-resources-list more-resources-list-formulations">
<li>Micardis</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to hydrochlorothiazide / telmisartan: oral tablet</i></p><h3>General</h3><p>The most common adverse effect was upper respiratory tract infection.<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Sinusitis, upper respiratory tract infection, cough</p><p><b>Uncommon</b> (0.1% to 1%): Dyspnea</p><p><b>Rare</b> (less than 0.1%): Bronchitis, pharyngitis, respiratory distress, pneumonitis, pulmonary edema</p><p></p><p>Hydrochlorothiazide:</p><p><b>Very common</b> (10% or more): Upper respiratory tract infection (10%)</p><p><b>Common</b> (1% to 10%): Sinusitis</p><p><b>Frequency not reported</b>: Respiratory distress, pneumonitis, pulmonary edema</p><p></p><p>Telmisartan:</p><p><b>Common</b> (1% to 10%): Sinusitis, upper respiratory tract infection</p><p><b>Uncommon</b> (0.1% to 1%): Cough</p><p><b>Frequency not reported</b>: Asthma, rhinitis, dyspnea, epistaxis</p><p><b>Postmarketing reports</b>: Interstitial lung disease<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, influenza-like symptoms, pain</p><p><b>Uncommon</b> (0.1% to 1%): Chest pain</p><p></p><p>Hydrochlorothiazide:</p><p><b>Common</b> (1% to 10%): Fatigue, influenza-like symptoms</p><p><b>Frequency not reported</b>: Weakness, pyrexia</p><p></p><p>Telmisartan:</p><p><b>Common</b> (1% to 10%): Fatigue, influenza-like symptoms</p><p><b>Uncommon</b> (0.1% to 1%): Asthenia</p><p><b>Frequency not reported</b>: Earache, fever, malaise, leg edema, peripheral edema, dependent edema, chest pain</p><p><b>Postmarketing reports</b>: Weakness, edema, face edema, pain<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Dizziness, headache</p><p><b>Uncommon</b> (0.1% to 1%): Syncope, paresthesia, vertigo</p><p></p><p>Hydrochlorothiazide:</p><p><b>Common</b> (1% to 10%): Dizziness</p><p><b>Frequency not reported</b>: Lightheadedness</p><p></p><p>Telmisartan:</p><p><b>Common</b> (1% to 10%): Dizziness</p><p><b>Rare</b> (less than 0.1%): Somnolence</p><p><b>Frequency not reported</b>: Tinnitus, migraine, hypoesthesia, cerebrovascular disorder, vertigo, paresthesia, hypoesthesia, involuntary muscle contraction</p><p><b>Postmarketing reports</b>: Headache, syncope<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Diarrhea, nausea</p><p><b>Uncommon</b> (0.1% to 1%): Dry mouth, flatulence</p><p><b>Rare</b> (less than 0.1%): Abdominal pain, constipation, dyspepsia, vomiting, gastritis</p><p></p><p>Hydrochlorothiazide:</p><p><b>Common</b> (1% to 10%): Diarrhea, nausea</p><p><b>Frequency not reported</b>: Sialadenitis, pancreatitis, stomach discomfort, cramping, gastric irritation</p><p></p><p>Telmisartan:</p><p><b>Common</b> (1% to 10%): Diarrhea, nausea</p><p><b>Rare</b> (less than 0.1%): Stomach discomfort</p><p><b>Frequency not reported</b>: Hemorrhoids, gastroenteritis, enteritis, gastroesophageal reflux, toothache, non-specific gastrointestinal disorder, flatulence, constipation, gastritis, dry mouth, </p><p><b>Postmarketing reports</b>: Dyspepsia, abdominal pain<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Common</b> (1% to 10%): BUN increased 11.2 mg/dL or greater, serum creatinine increased 0.5 mg/dL or greater</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Nephritis interstitial, renal dysfunction, renal failure</p><p></p><p>Telmisartan:</p><p><b>Uncommon</b> (0.1% to 1%): Renal impairment, acute renal failure<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection</p><p><b>Uncommon</b> (0.1% to 1%): Erectile dysfunction</p><p><b>Frequency not reported</b>: Impotence</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Glycosuria</p><p></p><p>Telmisartan:</p><p><b>Uncommon</b> (0.1% to 1%): Urinary tract infection</p><p><b>Frequency not reported</b>: Micturition frequency, cystitis, impotence</p><p><b>Postmarketing reports</b>: Erectile dysfunction<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Common</b> (1% to 10%): Hemoglobin decreased 2 g/dL or greater</p><p><b>Uncommon</b> (0.1% to 1%): Hematocrit decreased 9% or more</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Aplastic anemia, hemolytic anemia, bone marrow depression, leukopenia, neutropenia, agranulocytosis, thrombocytopenia</p><p></p><p>Telmisartan:</p><p><b>Uncommon</b> (0.1% to 1%): Anemia</p><p><b>Rare</b> (less than 0.1%): Eosinophilia, thrombocytopenia, hemoglobin decreased<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Uncommon</b> (0.1% to 1%): Tachycardia, arrhythmias, hypotension, orthostatic hypotension</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Vasculitis necrotizing</p><p></p><p>Telmisartan:</p><p><b>Uncommon</b> (0.1% to 1%): Bradycardia</p><p><b>Frequency not reported</b>: Palpitation, angina pectoris, abnormal ECG, flushing, hypertension</p><p><b>Postmarketing reports</b>: Atrial fibrillation, congestive heart failure, myocardial infarction, blood pressure increased, hypertension aggravated, hypotension, postural hypotension<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Uncommon</b> (0.1% to 1%): Back pain, muscle spasm, myalgia</p><p><b>Rare</b> (less than 0.1%): Arthralgia, muscle cramp, pain in limb, blood creatine phosphokinase increased</p><p><b>Frequency not reported</b>: Leg pain, cramps in legs</p><p><b>Postmarketing reports</b>: Exacerbation or activation of systemic lupus erythematosus</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Lupus-like syndrome, muscle spasm</p><p></p><p>Telmisartan:</p><p><b>Rare</b> (less than 0.1%): Arthrosis, tendon pain, tendonitis, tenosynovitis</p><p><b>Frequency not reported</b>: Arthritis, arthralgia, leg pain, leg cramps, myalgia</p><p><b>Postmarketing reports</b>: Back pain, muscle cramps, creatine phosphokinase increased, rhabdomyolysis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Uncommon</b> (0.1% to 1%): Hypokalemia, blood uric acid increased</p><p><b>Rare</b> (less than 0.1%): Hyperuricemia, hyponatremia</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Diabetes mellitus inadequate control, anorexia, appetite decreased, electrolyte imbalance, hypercholesterolemia, hyperglycemia, hypovolemia, triglycerides increased, hyperuricemia</p><p></p><p>Telmisartan:</p><p><b>Uncommon</b> (0.1% to 1%): Hyperkalemia</p><p><b>Rare</b> (less than 0.1%): Hypoglycemia in diabetic patients</p><p><b>Frequency not reported</b>: Diabetes mellitus, gout, hypercholesterolemia</p><p><b>Postmarketing reports</b>: Uric acid increased<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Uncommon</b> (0.1% to 1%): Anxiety</p><p><b>Rare</b> (less than 0.1%): Depression, insomnia, sleep disorder</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Restlessness</p><p></p><p>Telmisartan:</p><p><b>Frequency not reported</b>: Nervousness, insomnia, anxiety, depression<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Rare</b> (less than 0.1%): Angioedema, erythema, pruritus, rash, hyperhidrosis, urticaria</p><p><b>Frequency not reported</b>: Sweating increased</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Photosensitivity reactions, skin vasculitis, toxic epidermal necrolysis, cutaneous lupus erythematosus-like reactions, reactivation of cutaneous lupus erythematosus, erythema multiforme, Stevens-Johnson syndrome, exfoliative dermatitis, purpura, urticaria</p><p></p><p>Telmisartan:</p><p><b>Rare</b> (less than 0.1%): Eczema, drug eruption, toxic skin eruption, toxicoderma, rash, angioedema</p><p><b>Frequency not reported</b>: Dermatitis, sweating increased, pruritus</p><p><b>Postmarketing reports</b>: Urticaria, erythema<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Rare</b> (less than 0.1%): Abnormal hepatic function/liver disorder, hepatic enzyme increased</p><p><b>Frequency not reported</b>: Serum bilirubin increased</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Jaundice hepatocellular, jaundice cholestatic</p><p></p><p>Telmisartan:</p><p><b>Postmarketing reports</b>: Abnormal hepatic function/liver disorder<sup>[Ref]</sup></p><h3>Ocular</h3><p><b>Rare</b> (less than 0.1%): Visual disturbance, vision blurred</p><p></p><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Xanthopsia, acute myopia, acute angle-closure glaucoma, transient blurred vision</p><p></p><p>Telmisartan:</p><p><b>Frequency not reported</b>: Conjunctivitis, abnormal vision<sup>[Ref]</sup></p><h3>Immunologic</h3><p>Hydrochlorothiazide:</p><p><b>Frequency not reported</b>: Anaphylactic reactions, hypersensitivity, allergy</p><p></p><p>Telmisartan:</p><p><b>Rare</b> (less than 0.1%): Sepsis, hypersensitivity, anaphylactic reactions</p><p><b>Frequency not reported</b>: Allergy, infection, fungal infection, abscess, otitis media<sup>[Ref]</sup></p><p id="ref_1">1. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. "Product Information. Micardis (hydrochlorothiazide-telmisartan)" Boehringer-Ingelheim, Braintree, MA. </p><h2>More about Micardis HCT (hydrochlorothiazide / telmisartan)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>14 Reviews</li>
<li>Generic Availability</li>
<li>Drug class: angiotensin II inhibitors with thiazides</li>
<li>FDA Alerts (1)</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Micardis HCT &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
</ul><h3>Other Formulations</h3><ul class="more-resources-list more-resources-list-formulations">
<li>Micardis</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>High Blood Pressure</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>